Holen Sie sich die Stockscreener-App
233.31
0.53%
1.22
Schlusskurs vom Vortag:
$232.09
Offen:
$233.41
24-Stunden-Volumen:
688.14K
Relative Volume:
0.62
Marktkapitalisierung:
$12.16B
Einnahmen:
$45.08B
Nettoeinkommen (Verlust:
$188.00M
KGV:
68.81
EPS:
3.3907
Netto-Cashflow:
$251.00M
1W Leistung:
+1.50%
1M Leistung:
+17.90%
6M Leistung:
+28.55%
1J Leistung:
+2.07%
1-Tages-Spanne:
$229.28
$235.99
1-Wochen-Bereich:
$223.24
$243.50
52-Wochen-Spanne:
$121.06
$243.50
Molina Healthcare Inc Stock (MOH) Company Profile
Firmenname
Molina Healthcare Inc
Sektor
Branche
Telefon
(562) 435-3666
Adresse
200 OCEANGATE, SUITE 100, LONG BEACH, CA
Compare MOH vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MOH
Molina Healthcare Inc
|
233.31 | 12.16B | 45.08B | 188.00M | 251.00M | 3.3907 |
UNH
Unitedhealth Group Inc
|
424.62 | 385.62B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
104.15 | 132.89B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
416.23 | 90.39B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
293.46 | 77.63B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
392.22 | 47.09B | 137.20B | 1.15B | 1.27B | 9.3439 |
Molina Healthcare Inc Stock (MOH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-10-24 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-10-16 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-07-25 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-25 | Herabstufung | Truist | Buy → Hold |
| 2025-07-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-06-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-04-22 | Eingeleitet | Bernstein | Outperform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-28 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-06-20 | Eingeleitet | UBS | Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-03 | Fortgesetzt | JP Morgan | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-11-22 | Fortgesetzt | Deutsche Bank | Hold |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Underweight |
| 2021-03-30 | Eingeleitet | Credit Suisse | Outperform |
| 2021-03-10 | Eingeleitet | Mizuho | Buy |
| 2021-02-19 | Fortgesetzt | Barclays | Overweight |
| 2021-01-21 | Eingeleitet | Goldman | Neutral |
| 2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Fortgesetzt | SVB Leerink | Outperform |
| 2020-06-16 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-04-14 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2020-04-08 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2019-10-30 | Herabstufung | Jefferies | Buy → Hold |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-07-31 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-03 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-05-31 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-04-30 | Bestätigt | BofA/Merrill | Underperform |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-13 | Hochstufung | Jefferies | Hold → Buy |
| 2018-10-12 | Herabstufung | Jefferies | Buy → Hold |
| 2018-10-10 | Eingeleitet | Evercore ISI | In-line |
| 2018-06-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-06-22 | Hochstufung | Jefferies | Hold → Buy |
| 2018-03-28 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-16 | Hochstufung | JP Morgan | Neutral → Overweight |
Alle ansehen
Molina Healthcare Inc Aktie (MOH) Neueste Nachrichten
Daily Brief Health Care: Centene Corp, FibroBiologics, Molina Healthcare, Solvonis Therapeutics and more - Smartkarma
How Investors Are Reacting To Molina Healthcare (MOH) Shifting Russell Style Indices After Illinois Medicaid Win - simplywall.st
Molina Healthcare, Inc. (MOH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RBC Adjusts Price Target on Molina Healthcare to $248 From $216, Maintains Sector Perform Rating - Moomoo
Can Centene's Operational Execution Keep Margin Recovery on Track? - TradingView
Molina Healthcare highlights Medicaid and Medicare strength as managed care demand grows - ad-hoc-news.de
Molina Healthcare focuses on Medicaid and Medicare growth as a managed care specialist - ad-hoc-news.de
Molina Healthcare stock hits 52-week high at 237.96 USD - Investing.com
Molina Healthcare stock hits 52-week high at 237.96 USD By Investing.com - Investing.com South Africa
Molina Healthy Advantage Silver 2470 from Molina HealthcareMedicare plan with predictable copays - ad-hoc-news.de
Bronstein, Gewirtz & Grossman, LLC Is Investigating Molina Healthcare, Inc. (MOH) And Encourages Investors to Connect - ACCESS Newswire
Molina Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
Molina Healthcare focuses on managed Medicaid. Investors watch its role in U.S. government-backed co - ad-hoc-news.de
Molina Healthcare’s SWOT analysis: stock faces margin pressures By Investing.com - Investing.com South Africa
Index Shift Toward Value Might Change The Case For Investing In Molina Healthcare (MOH) - Yahoo Finance
Molina Healthcare’s SWOT analysis: stock faces margin pressures - Investing.com
Barclays Raises Price Target for Molina Healthcare (MOH) | MOH S - GuruFocus
Alignment Healthcare Outlook as MA Growth Fuels Margin Gains in 2026 - TradingView
Molina Healthcare stock edges higher as Medicaid and Medicare growth supports outlook - ad-hoc-news.de
Molina Healthcare Inc (MOH) Stock Analysis: Navigating a Challenging Landscape with Strategic Insights - DirectorsTalk Interviews
Molina Marketplace Bronze Plan from Molina Healthcarebudget health coverage for US families - AD HOC NEWS
Molina Healthcare (MOH) Q1 2026 Earnings Call Transcript - Fortune
Bronstein, Gewirtz & Grossman, LLC Encourages Molina Healthcare, Inc. (MOH) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Price to earnings forward of Molina Healthcare Inc – NYSE:MOH - TradingView
Molina Marketplace Bronze 1 from Molina Healthcarelow-cost ACA plan with lean benefits - AD HOC NEWS
Molina Healthcare outlines its managed care strategy as a US Medicaid specialist - AD HOC NEWS
‘Big Short’ Investor Michael Burry Sticks With MOH Bet At $154 — Plans To Add More Shares - Stocktwits
Does Molina Healthcare (MOH) Belong in Value Indices or Growth Portfolios After Its Russell Reclassification? - Sahm
Molina Healthcare focuses on managed care growth as a key US Medicaid and Medicare player - AD HOC NEWS
Molina Healthcare stock steadies on a thin catalyst set. Investors watch managed care guidance. - AD HOC NEWS
Q1 Rundown: Molina Healthcare (NYSE:MOH) Vs Other Health Insurance Providers Stocks - Yahoo Finance
Form 4 Molina Healthcare Inc For: 2 July By Investing.com - Investing.com Nigeria
Molina Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
Director equity grant at Molina (NYSE: MOH) valued at $55,000 - Stock Titan
Molina Healthcare (MOH) director receives 237-share quarterly equity award - Stock Titan
Molina Healthcare (MOH) director receives quarterly $55,000 equity stock grant - Stock Titan
Molina Healthcare (MOH) director granted $55K quarterly stock award via trust - Stock Titan
Molina Healthcare (MOH) director gets 237-share grant under 2025 equity plan - Stock Titan
Molina Healthcare (MOH) director granted 237-share quarterly equity award - Stock Titan
Molina Healthcare (MOH) director awarded quarterly stock grant valued at $55,000 - Stock Titan
Molina Healthcare (NYSE: MOH) director gets $55,000 quarterly stock grant - Stock Titan
Molina Healthcare (MOH) director receives 237-share quarterly equity grant under 2025 plan - Stock Titan
Molina Healthcare (MOH) COO adds 144 shares via ESPP purchase - Stock Titan
Molina Healthcare (MOH) CLO adds 138 shares under 2019 employee stock purchase plan - Stock Titan
Molina Healthcare (MOH) EVP Debra Bacon logs ESPP share purchase and tax withholding - Stock Titan
Molina Healthcare focuses on managed care growth as investors watch US health coverage trends - AD HOC NEWS
Molina Healthcare focuses on managed Medicaid growth as US health coverage needs evolve - AD HOC NEWS
Molina Healthcare (MOH) Gets A Payment Boost, Is The Stock Still A Bargain? - Sahm
Molina Healthcare Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Is Molina Healthcare (MOH) Stock Undervalued Right Now? - Yahoo Finance
Molina Healthcare focuses on Medicaid and Medicare growth as managed care demand stays solid - AD HOC NEWS
Finanzdaten der Molina Healthcare Inc-Aktie (MOH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):